---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281044529.md"
description: "Reviva Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q4 EPS results."
datetime: "2026-03-30T14:45:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281044529.md)
  - [en](https://longbridge.com/en/news/281044529.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281044529.md)
---

# 

Reviva Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q4 EPS results.

### Related Stocks

- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [LABD.US](https://longbridge.com/en/quote/LABD.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [RVPH.US](https://longbridge.com/en/quote/RVPH.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)

## Related News & Research

- [Reviva Pharmaceuticals Q1 net loss narrows on lower expenses](https://longbridge.com/en/news/286314912.md)
- [GRI Bio Highlights Promising Phase 2a IPF Data, Outlook](https://longbridge.com/en/news/286422240.md)
- [vTv Therapeutics posts Q1 profit on license payment](https://longbridge.com/en/news/286309828.md)
- [HC Wainwright Analysts Increase Earnings Estimates for CTMX](https://longbridge.com/en/news/286258226.md)
- [Precigen Q1 revenue beats estimates on PAPZIMEOS launch](https://longbridge.com/en/news/286311056.md)